|
|
President Of Sales at Investigational Drug Delivery
Stephen Corba has built a reputation over the past decade as a knowledgeable, results-driven professional in the pharmaceutical distribution and sales industry. After gaining 10 years of valuable experience at 2 leading pharmaceutical companies, AstraZeneca and Avenel Surgical & Pharmaceuticals, Corba accepted the position of President of Sales at Investigational Drug Delivery (IDD) in June 2011. A New Jersey-based company focusing solely on the sourcing of medical products for use in clinical research, IDD is becoming a leader in this sector of the industry. Working directly with clinical researchers and their pharmaceutical procurement staff, Stephen Corba and IDD strive to provide accurate and efficient service to their clients, delivering the products needed for important medical research.
After completing his education at Kaplan University and Rutgers University, Stephen Corba got his start in the pharmaceutical industry in 2001, when he was hired as a sales specialist at AstraZeneca. Drawing on his years of experience as an account manager for both The Coca-Cola Company and DHL Worldwide Express, Corba excelled at developing and maintaining business contact relationships, and quickly surpassed sales goals for his position at AstraZeneca. In 2003, Stephen Corba was promoted to Hospital Sales Specialist, responsible for sales of cardiovascular and central nervous system medications such as Seroquel, Merrem IV, Nexium IV, Crestor, Toprol XL, and Atacand to hospitals and teaching institutions in the northern New Jersey area. After more than six years with AstraZeneca, Corba accepted a position as a Regional Account Specialist with Avenel Surgical & Pharmaceuticals in 2007. Among his duties there, Stephen Corba was responsible for the retail sale of pharmaceutical products and surgical supplies, as well as working with Group Purchasing Operations (GPOs).
Stephen Corba's Publications
-
|
Interview with Stephen Corba, Stephen Corba
November, 2011
A health care professional and seasoned industry executive, Stephen Corba operates as the President of Sales for Investigational Drug Delivery. With much experience in the sales and marketing arena, Stephen Corba continues to provide invaluable insight and leadership in his current role. We spoke with Mr. Corba to discuss his professional history and current areas of focus.
Q. Before embarking on your professional career, where did you carry out your studies?
A. I attended Kaplan University as well as Rutgers in New Brunswick.
Q. I understand you did not begin your career in pharmaceuticals. What jobs did you initially have after leaving academia?
A. In August 1999, I accepted a position with The Coca-Cola Company, and I later worked as an Account Manager with DHL Worldwide Express. These positions taught me a great deal about networking, relationship building, and client satisfaction. I also developed my sales and marketing knowledge and was able to increase territory sales by more than one-third at DHL.
Q. How did you first enter the pharmaceutical industry?
A. I was hired by AstraZeneca as a Respiratory/Primary Care Sales Specialist in 2001. I focused on cardiovascular and respiratory products. In this role, I increased my knowledge of the industry and developed promotional and training programs for health care professionals.
Q. What other roles have you taken during the past decade?
A. I acted as a Hospital Sales Specialist and as a Cardiovascular Account Specialist, spending several years in each position, and was later hired by Avenal Surgical and Pharmaceuticals to serve as an Account Specialist and Account Executive. After several years in those positions, I earned the title of Vice President of Sales.
Q. In your current role, what are your main responsibilities?
A. Mainly, I focus on my relationships with research nurses, clinical research coordinators, clinical investigators, and research managers in order to provide appropriate and necessary products to various medical facilities.
|
-
Stephen Corba Explains Nexium I.V.
, Stephen Corba's Blog on Bigsight
November, 2011
Since 2001, I have worked as a pharmaceutical sales representative at several companies, including AstraZeneca, Avenel Surgical and Pharmaceuticals, and Investigational Drug Delivery (IDD). Throughout this time, I learned a great deal about the medical and sales industries and conducted business with professionals from a number of fields. Although I have participated in the marketing and distribution of many medications, I am particularly proud of my work with Nexium I.V.
While acting as a Hospital Sales Specialist with AstraZeneca, I taught district sales managers in the firm’s primary care division about the benefits of Nexium I.V.as well as how to explain the drug to potential customers. During this period, I also contracted with hospitals, pharmacies, and physicians and garnered exclusive status with several organizations.
Released in 2005, Nexium I.V. acts a short-term treatment for gastroesophageal reflux disease (GERD). Unlike previous versions of the drug, doctors can deliver it intravenously or via injection. Patients who are unable to swallow capsules or have erosive esophagitis may receive Nexium I.V. for relief from GERD symptoms.
A 10-day treatment, Nexium I.V. must be intravenously injected once daily for at least three minutes or intravenously infused for between 10 and 30 minutes. The results of Nexium I.V. have been found to be comparable to those of the oral dose, including its positive effects on erosive esophagitis. Once patients can swallow Nexium pills, they should discontinue use of its I.V. form.
Public Domain, posted by sprocket-trials.blogspot.com
About the Author:
In addition to his accomplishments with Nexium I.V., Stephen Corba has handled sales efforts for Crestor, Seroquel, Rhinocort Aqua, and other medications. Today, as President of Sales with IDD, Stephen Corba interacts with various people in the medical profession to provide them with materials they need for clinical trials.
|
|
